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N the past ten years, there have been a number of major 
scientific discoveries in the field of epidermal differenti- 
ation. We owe many of these findings to the develop- 
ment of model tissue culture systems, and to technological 
advances in molecular biology. In this article, I will review 
some important aspects of the biology of terminal differenti- 
ation in vivo and in vitro, and highlight the recent advances 
in elucidating the molecular mechanism underlying these 
processes. 
The Program of Terminal Differentiation 
The epidermis is a stratified squamous epithelium that forms 
the protective covering of the skin. Only the innermost, basal 
layer of epidermal cells has the capacity for DNA synthesis 
and mitosis. Under an as yet unidentified trigger of terminal 
differentiation, a basal cell will begin its journey to the skin 
surface. In transit, it undergoes a  series of morphological 
and biochemical changes that culminate in the production of 
dead,  flattened, enucleated squames,  which are  sloughed 
from the surface, and continually replaced by inner cells 
differentiating outward. 
The process of epidermal growth and differentiation has 
been subdivided into four parts. Basal cells are distinguished 
by an intracellular cytoskeleton composed of  a relatively dis- 
persed, but extensive, network of keratin filaments. These 
filaments are made of a 1:1 ratio of two distinct keratin pro- 
te~ns: K5 (58 kD) and K14 (50 kD) (Nelson and Sun, 1983). 
Additional hallmarks of basal cells, also common to spinous 
cells, are desmosomes, which are calcium-activated mem- 
brane junctions that interconnect the cells into a three-di- 
mensional lattice (for review,  see Franke et al.,  1987).  The 
four to eight layers of suprabasal spinous cells are postmi- 
totic, but metabolically active. These cells devote much of 
their protein synthesizing machinery to manufacturing two 
new keratins, K1 (67 kD) and K10 (56.5 kD), forming cyto- 
skeletal  filaments that  aggregate  into  thin  (tonofilamen0 
bundles (Eichner et al.,  1986).  In addition, spinous cells 
make glutamine and lysine-rich envelope proteins, such as 
involucrin, which are deposited on the inner surface of the 
plasma membrane of each cell (Rice and Green, 1979). Also 
made at this time are membrane-coating granules,  which 
will subsequently fuse with the plasma membrane and re- 
lease lipids into the intercellular spaces of granular and stra- 
tum corneum cells (Swartzendruber et al., 1989). AS spinous 
cells reach the granular layer, they stop generating keratin 
and envelope proteins, and make their final tailoring in pro- 
tein synthesis, including production of filaggrin, a histidine- 
rich, basic protein which may be involved in the bundling of 
tonofilaments into larger, macrofibrillar cables (Fleckman et 
al., 1985; Rothnagel and Steinert, 1990).  This process of in- 
creased filament packing is thought to enable the keratin ilia- 
merits to be among the few survivors of the massive destruc- 
tive phase which soon ensues. Loricrin, a recently described 
and major component of the cornified envelope is also syn- 
thesized at this late stage (Mehrel et al.,  1990).  As each 
differentiating cell becomes permeable, a calcium influx ac- 
tivates epidermal transglutaminase, which then catalyzes the 
formation of ¢-(3,-glutamyl) lysine isopeptide bonds, thereby 
biochemically cross-linking  the  envelope  proteins  into  a 
cage (Rice and Green,  1979).  As other lytic enzymes are 
released, all vestiges of metabolic activity terminate, and the 
resulting flattened squames are merely cellular skeletons, 
filled with macrofibrils of keratin filaments. The  stratum 
corneum,  composed of terminally differentiated keratino- 
cytes sealed together by lipids, is an impermeable, insoluble, 
and highly protective fortress, which keeps microorganisms 
out and essential bodily fluids in. 
Reproducing Epidermis In Vitro 
Among the most significant contributions to epidermal cell 
growth in culture are the pioneering studies of Rheinwald 
and Green (for review,  see Rheinwald, 1980),  who realized 
that epidermal cells are not only dependent upon EGE but 
also some as yet unidentified fibroblast factor. Thus, when 
seeded on a  lawn of x-irradiated or mitomycin C-treated 
fibroblasts, and in medium containing the appropriate serum 
lot, cAMP-inducing agent, growth factors, and various addi- 
tional nutrients, epidermal cells grow optimally for several 
hundred generations in culture. Despite the desirability of 
this system for generating rapidly growing keratinocytes, it 
is not optimal for differentiation, since only a few layers of 
cells  form  at  confluence,  and  many of the  biochemical 
changes characteristic of terminal differentiation, such as 
K1, K10 and filaggrin expression, do not occur (Fuchs and 
Green,  1980;  Asselineau et al.,  1986). 
A  number of laboratories have contributed to methods 
aimed at optimizing terminal differentiation in vitro,  and 
from these studies, clues to extracellular controls of keratini- 
zation have been obtained. One of these factors is calcium, 
which is a necessary prerequisite for a variety of differentia- 
tive processes, including stratification, assembly of desmo- 
somes, and activation of epidermal transglutaminase (Rice 
and Green, 1979; Hennings et al.,  1980; Watt et al.,  1984; 
Duden and Franke, 1988). Another important group of regu- 
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differentiation in stratified squamous epithelia both in vivo 
(Fell and Mellanby,  1953) and in vitro (Yuspa and Harris, 
1974;  Fuchs  and Green,  1981).  When retinol  is removed 
from serum,  cultured epidermal cells display many of the 
morphological and biochemical characteristics  of terminal 
differentiation (Fuchs and Green,  1981).  These features in- 
clude stratification, cell adhesiveness, reduced cell motility, 
and expression of K1 and K10. 
While calcium and retinoids  are clearly important,  cul- 
tures grown on feeder layers in the presence of low concen- 
trations of retinol and high concentrations  of calcium pro- 
duce basal keratinocytes and one to two layers of squames, 
but generate very few spinous and granular cells. A clue for 
retaining these earlier stages of epidermal differentiation in 
culture came from studies by researchers culturing epider- 
mal cells on floating lattices of collagen at the air-liquid in- 
terface (see Asselineau et al., 1986 for previous references). 
In initial attempts, basal cells were often flattened rather than 
cuboidal, and no visible granular layer was present. Despite 
these shortcomings,  four to five layers of spinous-like cells 
and four to five layers of comified cells were consistently ob- 
tained with floating cell cultures. From these studies, it was 
clear that when epidermal cells are exposed to the air and 
receive  their  nutrients  via  diffusion  through  an  artificial 
dermis,  their differentiation  is significantly enhanced  (As- 
selineau et al.,  1986). 
We now know that a combination of optimal serum lots, 
calcium, retinoids, and other nutrients, coupled with cultur- 
ing epidermal cells on a floating raft of collagen and fibro- 
blasts at the air-liquid interface, results in a near optimal bal- 
ance between growth and differentiation (Kopan et al., 1987; 
Choi and Fuchs,  1990,  see Fig.  1 A).  Tritiated thymidine 
labeling and examination of mitotic indices reveal a single 
layer of cuboidal-shaped basal cells, which express K5 and 
K14 (Kopan and Fuchs, 1989). As cells leave this layer, they 
synthesize  spinous  proteins,  including  K1  and  involucrin 
(Asselineau et al.,  1986; Kopan et al.,  1987;  see Fig.  1, B 
and C, respectively). Six to eight layers of K1/K10-synthesiz- 
ing cells are produced before a filaggrin-expressing granular 
layer is reached (Fig. 1 D). Above the granular layer, stratum 
corneum-like  layers  are  seen.  Unlike  epidermis  in  vivo, 
where dead squames are sloughed from the skin surface, the 
raft squames have nowhere to go and accumulate at the top 
of the tissue. 
Molecular Controls of  Epidermal Growth and 
Differentiation: Positive Growth Regulators 
The search for an optimal culture system uncovered a num- 
ber of e~tracellular  regulators  controlling  the balance be- 
tween growth  and  terminal  differentiation.  Stimulators  of 
kcratinocyte growth include EGF (Rheinwald,  1980), trans- 
forming  growth  factor  a  (TGF-~) ~ (Coffey et  al.,  1987; 
Barrandon  and Green,  1987),  low 00-7-10  -1° M) concen- 
trations of retinoic acid (Fuchs and Green, 1981; Kopan and 
Fuchs,  1989),  kcratinocyte  growth  factor  (Finch  et  al., 
1989), and two cytokines, IL-6 (Grossman et al., 1989) and 
IL-I~ (Ansel et al.,  1988; Kupper et al.,  1989). Of these, 
1. Abbreviations used in this paper: RA, retinoic acid; RAR, retinoic acid 
receptor; TGF, transforming growth factor. 
EGF and TGF-ot have been the most extensively studied. The 
targets of both EGF and TGF-ot are the tyrosine kinase ac- 
tivatable EGF receptors, located primarily on the surface of 
basal cells (Green et al.,  1987). However, as implied by a 
number of experiments,  these factors do not act simply as 
mitogens (Barrandon and Green,  1987). In fact, when kera- 
tinocyte colonies are small,  cell growth is exponential and 
usually not markedly influenced by additional growth sup- 
plements.  It is only when colonies become larger that sup- 
plemental factors play significant role in colony expansion. 
This acquired factor dependency appears to arise from the 
fact that colony growth occurs predominantly at the periph- 
ery, and hence larger colonies are dependent upon factors 
that increase cell migration.  TGF-c~ (Barrandon and Green, 
1987) and retinoids (Fuchs and Green,  1981) are especially 
potent in enhancing migration of keratinocytes, and it may 
be that the growth stimulatory effects of these factors are at 
least in part related to this ability. 
TGF-o~ differs from EGF in that it is synthesized by kera- 
tinocytes both in vitro and in vivo (Coffey et al.,  1987; Gott- 
lieb et al.,  1988; Elder et al.,  1989). Since epidermal cells 
autoregulate their own growth via TGF-tx  production,  it is 
perhaps not surprising to find that such control can go awry, 
leading to uncontrolled growth. Several reports have impli- 
cated an increase in EGF receptors with epidermal tumori- 
genesis (Yamamoto et al.,  1986;  Ozanne et al.,  1986). In 
addition,  it was recently reported that psoriatic epidermis 
contained higher levels of TGF-t~ than normal skin, suggest- 
ing that overexpression of TGF-t~ might contribute to hyper- 
proliferative diseases of the skin (Gottlieb et al., 1988; Elder 
et al.,  1989). This hypothesis is an attractive one, although 
it remains  to be shown whether the increase in TGF-o~ in 
psoriasis is causal or consequential.  Thus,  while there are 
later steps in the keratinocyte growth cycle that can be altered 
thereby leading to epidermal hyperproliferation and malig- 
nant transformation  (for examples,  see Roop et al.,  1986; 
Bailleul et al., 1990; Greenhalgh et all., 1990; Wilson et al., 
1990), TGF-a seems to be involved in the initial events con- 
trolling the proper balance between growth and differenti- 
ation. 
Negative Growth Regulators 
Withdrawal from the cell cycle seems to be a prerequisite for 
irreversible  commitment  of a  keratinocyte  to  terminally 
differentiate. In recent years, several noncytotoxic, autocrine 
inhibitors  of  keratinocyte  growth  have  been  uncovered. 
While epidermal chalones (see, for example, Richter et al., 
1990) will undoubtedly receive more attention in the future, 
the most extensively studied negative regulators are the TGF- 
/3s, which act at picomolar concentrations  to inhibit DNA 
synthesis and cell division (Shipley et al.,  1986; Kopan et 
al.,  1987;  Bascom et al.,  1989).  The effect of TGF-/3s  on 
growth is reversible, at least within a 48-h frame, and is not 
accompanied by gross changes in protein or RNA synthesis 
(Bascom et al., 1989). While TGF-/~s inhibit growth of basal 
cells, their natural expression in epidermis seems to be pre- 
dominantly in suprabasal, differentiating layers. Indeed dur- 
ing mammalian development, expression of TGF-/32 mRNA 
(Pelton et al., 1989) and a related Vgr-1 mRNA (Lyons et al., 
1989) coincides with epidermal stratification and keratiniza- 
tion. An interesting parallel occurs in Drosophila, where a 
TGF-/~-like  gene called decapentaplegic  is expressed dor- 
The Journal  of Cell Biology,  Volume I 1  I,  1990  2808 Figure 1. Morphology and expression of biochemical markers of differentiation by cultured human epidermal cells. Human epidermal cells 
from newborn foreskins were isolated and cultured according to Rheinwald (1980). Cells were transferred to a dish containing a lattice 
of collagen and fibroblasts, and at confluence, the epidermal cells and the lattice were raised to the air-liquid interface, and cultured for 
an additional three weeks (Asselineau et al.,  1986; Kopan et al.,  1987). The "tissue" was then fixed in Carnoy's solution, embedded in 
paraffin, and sectioned (5/~m). (A) Section stained with hematoxylin and eosin (Choi and Fuchs, 1990); (B) section treated with anti-human 
K1 antisera and subjected to indirect immunofluorescence (Kopan et al.,  1987); (C) section treated with anti-human involucrin and sub- 
jected to indirect immunogold enhancement (Choi and Fuchs, 1990); (D) section treated with anti-human filaggrin and subjected to indirect 
immunogold enhancement (Choi and Fuchs, 1990). s.c., stratum corneum; gr, granular layer; sp, spinous layers; ha, basal layer; dr, dermis. 
Bar:  (A, C, and D) 27.5/,m; (B) 15.5/zm. 
sally in early embryos and localized later in the imaginal 
disks, which will form much of the adult epidermis of the 
fly (Padgett et al.,  1987).  In adult mammalian epidermis 
both in vivo (Thompson et al.,  1989) and in vitro (Shipley 
et al., 1986; Van Obberghen-Schilling et al., 1988; Glick et 
al.,  1989, 1990; Bascom et al.,  1989; Pelton et al.,  1989), 
TGF-B1 and TGF-/T2 mRNAs are low, but detectable in the 
differentiating layers.  In  adult epidermis,  TGF-/~  mRNAs 
can be upregulated (a) in an autoregulatory fashion (Van Ob- 
berg,  hen-Schilling et al.,  1988; Bascom et al.,  1989), and 
(b) when mouse skin is treated with tumor-promoting agent 
(TPA) (Akhurst et al., 1988) or calcium (Glick et al., 1990), 
agents known to induce epidermal keratinization. Curiously, 
TPA also induces TGF-c~ expression, presumably in basal 
epidermal cells (Pittlekow et al.,  1989), a phenomenon that 
may explain the seemingly antagonistic effects of TPA, en- 
hancing growth and inducing differentiation in epidermis. 
Collectively, the timing and location of TGF4t mRNA ex- 
pression suggests that members of the TGF-O family may be 
involved  in  maintaining  the  cessation  of  growth  in  the 
differentiating cells of epidermis. 
Elucidating the functional significance of TGF-B expres- 
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and secreted by cells in a latent form, which must then be 
activated before interaction with TGF-/~ receptors on the cell 
surface (Lyons et al.,  1988;  Miyazono et al.,  1988).  Mere 
elevation of TGF-/~ mRNA expression is therefore not auto- 
matically an indication that active TGF-/~s are being pro- 
duced. An example of this is the production of latent TGF-~I 
by human keratinocytes cultured under serum-free condi- 
tions at neutral pH (Bascom et al., 1989). Thus, even though 
the correlation between suprabasal TGF-/3 mRNA expres- 
sion and cessation of growth in keratinizing cells is compel- 
ling, a causal relationship has not yet been unequivocally 
demonstrated, nor is it clear to what extent the expression 
of TGF-B mRNAs in vivo is an accurate reflection of active 
TGF-~ secretion. 
Because the effects of TGF-/~s on basal cell growth appear 
to be largely reversible,  it has been assumed that TGF-~s 
alone are not sufficient to induce terminal differentiation, a 
process thought to be irreversible. In support of this notion 
were early in vitro studies, showing that the biochemical in- 
dicators of terminal differentiation were not induced upon 
treatment of keratinocytes cultured on plastic with TGF-/3s 
(Kopan et al.,  1987; Bascom et al.,  1989).  More recent 
studies with differentiating  culture systems have revealed that 
at greatly elevated levels, TGF-/3s can influence biochemical 
markers of keratinization, but at these high levels, they in- 
hibit rather than promote, K1, K10, and filaggrin expression 
(Ma~nsbridge and Hanawalt,..1988;  Choi and Fuchs,  1990). 
At li|gh concentration, TGF-/~s also enhance expression of 
K6 (56 kD) and K16 (48 kD), keratins more commonly as- 
sociated with suprabasal layers of epidermis undergoing (a) 
wound healing (Mansbridge and Knapp, 1987) and (b) hyper- 
proliferation (Weiss et al., 1984; Stoler et al., 1988). Studies 
using floating epidermal cultures have shown that induction 
of K6 and K16 is accompanied by morphological changes 
typical of squamous cell carcinomas,  including increased 
stratification, vacuolization, and coilocyte formation (Choi 
and Fuchs, 1990). Interestingly, TGF-/~s seem to elicit these 
changes in keratinizing epidermal cells at least in part in- 
dependently of their action on basal cells. Collectively, these 
studies have led to the notion that the epidermal phenotype 
associated with wound healing and many hyperproliferative 
diseases may not relate to hyperproliferation, per se,  but 
rather is a  reflection of environmental changes, which, in 
some circumstances,  may include active TGF-Bs  (Mans- 
bridge  and  Hanawalt,  1988;  Kopan  and  Fuchs,  1989; 
Schermer et al.,  1989;  Choi and Fuchs,  1990). 
A  priori,  the  apparent  reversibility of TGF-/~-mediated 
growth inhibition may seem ironic in light of more recent 
findings  that  (a)  TGF-/3 mRNA  expression  is  largely 
confined to suprabasal, terminally differentiating cells, and 
(b)  TGF-Bs  can  upregulate  their  own  expression  (Van 
Obberghen-Schilling et al.,  1988;  Bascom et al.,  1989). 
However, the effects of  TGF-Bs at various stages of  epidermal 
differentiation seem to be quite different (Choi and Fuchs, 
1990),  and hence it may be relevant that the reversibility 
studies were conducted on dividing cells of the population, 
while TGF-/~ mRNA synthesis and autoregulation seem to 
take place in nondividing cells. In addition, it seems increas- 
ingly apparent that while cessation of cell growth by TGF-~s 
may be necessary, it is not sufficient for commitment to ter- 
minal differentiation. In a  model where a cascade of bio- 
chemical changes is necessary to enter and maintain the 
differentiation state, TGF-~/expression may be among the 
early  steps  in  the  pathway.  Interestingly,  one  step  after 
TGF-/~s in this putative cascade may be dowrtregulation of 
c-myc expression, which occurs in response to TGF-/~s and 
is abrogated by viral transforming proteins (Pietenpol et al., 
1990).  As the receptors of TGF-Bs are identified and local- 
ized, and as further studies are conducted, the molecular 
mechanisms underlying the effects of TGF-Bs on epidermal 
growth and differentiation should become more apparent. 
Retinoids 
While TGF-/3s seem to accentuate abnormal and inhibit nor- 
real differentiation, retinoids appear to inhibit both forms of 
epidermal differentiation (Kopan and Fuchs,  1989).  Thus, 
for example, in organ culture of chick epidermis, vitamin A 
can induce its transition from a keratinizing to a secretory 
epithelium (mucous metaplasia) (Fell and Mellanby, 1953). 
Excess retinoids in mammalian epidermal cultures can sup- 
press  differentiative features including K1/KI0 expression 
(Fuchs and Green,  1981), Kt/KI6 expression (Kopan and 
Fuchs,  1989),  cornified envelope production  (Yuspa  and 
Harris,  1974),  and filaggrin expression (Fleckman et al., 
1985). Many of  these effects are at least at the level of mRNA 
expression (Fuchs and Green,  1981; Kopan et al.,  1987; 
Kopan and Fuchs,  1989),  and quite likely at the transcrip- 
tional level as well (Agarwal et al., 1990; Blumenberg et al., 
1990). 
Recently, it was shown that 10  ~s M retinoic acid inhibited 
proliferation and concomitantly induced active TGF-32 in 
mouse keratinocytes (Glick et al., 1989). Conversely, when 
exposed to 10-7-10  4  M retinoic acid, human keratinocytes 
showed an increase in proliferation and cell migration, with 
no detectable TGF-~2 induction (Choi and Fuchs,  1990). 
Whether these differences are a reflection of species-specific 
variations in dose response to retinoids awaits further inves- 
tigation. Nevertheless, the discovery of an autocrine regula- 
tory loop between retinoids and TGF-/3s in some keratino- 
cytes under some conditions is exciting, and suggests that 
both factors may be involved in some common regulatory 
pathways. 
Determining  the  mechanism  of action  of retinoids on 
epidermal differentiation has been hampered by the fact that 
there are a number of intracellular regulators of retinoids. 
Among the first to be identified were cellular retinol binding 
protein (CRBP) and cellular retinoic acid binding protein 
(CRABP), barrel-shaped proteins initially thought to medi- 
ate the steroid hormone-like effects of retinoids on epidermal 
gene expression (Chytil and Ong, 1983). With the recent dis- 
covery of retinoic acid receptors (RARs) with sequence ho- 
mologies to  classical  steroid receptors  (see  Krust et al., 
1989;  Mangelsdorf et al.,  1990),  it now seems more likely 
that CRBP and CRABP play a role in storage or transport 
of retinoids, rather than in mediating the steroid hormone- 
like effects of retinoids. 
RAR-t~ and RAR-3, are expressed  in human epidermis 
(Rees and Redfern, 1989;  Kim, M., and E. Fuchs, unpub- 
lished data; Noji et al., 1989),  and of these, RAR-3, seems 
to be unique to skin (Krust et al., 1989). In situ hybridization 
studies have shown that RAR mRNAs are most abundant in 
the keratinizing layers of epidermis (Noji et al.,  1989).  No 
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fore seems likely that the effects of retinol are mediated via 
intracellular conversion to retinoic acid and subsequent in- 
teraction  with  RARs.  That  retinoic  acid  (RA)-induced 
suprabasal RARs mediate biochemical changes in epidermal 
differentiation  has yet to be unequivocally demonstrated. As- 
suming that this hypothesis is correct, the suprabasal loca- 
tion of RARs would explain why RA acts at least in part to 
inhibit suprabasal functions, and why culturing cells at an 
air-liquid interface enables suprabasal cells to differentiate 
via escape from the retinol-containing serum. 
It is intriguing to speculate that RARs and retinoic acid 
may act directly to negatively control transcription of a num- 
ber of differentiation-specific epidermal genes. Indeed, Blu- 
menberg et al.  (1990)  have recently reported preliminary 
studies suggesting that expression of a reporter gene driven 
by the 5' upstream sequences of several keratin genes is in- 
hibited by retinoids, and that this inhibition is enhanced by 
cotransfection with RAR genes. Clearly, in coming years, 
this topic will be one of great interest. Coupled with the fact 
that retinoids can influence both cell proliferation and migra- 
tion in basal cells as well as gene expression in terminally 
differentiating cells,  the effects  of retinoids on epidermal 
cells appear to be pleiotropic. Hence it will be important to 
elucidate whether the regulatory mechanisms involving reti- 
noids change with relative stage of keratinocyte differentia- 
tion, or whether a single biochemical pathway is used. Are 
RARer and RAR,y differentially  expressed in epidermis? Are 
their mechanisms of  action different? Do both transcriptional 
and posttranscriptional controls play a role in RA-mediated 
changes in keratinocyte protein expression? Are retinoids in- 
volved in the gate that controls commitment of an epidermal 
cell to undergo terminal differentiation?  As future studies are 
conducted, the answers to these questions should become 
more apparent. 
Calcium 
When cultured in medium containing 0.05  mM calcium, 
mouse keratinocytes grow as a monolayer, because desmo- 
some assembly is inhibited (Hennings et al.,  1980).  Upon 
a switch to high (1.2 mM) calcium, desmosomes form and 
cells stratify. After three to seven additional days in culture, 
squames containing cornified envelopes appear in the me- 
dium. These data indicate that at least some features of ter- 
minal differentiation  can be induced by calcium in vitro. Cal- 
cium also seems to play a role in mediating keratinization 
in  vivo:  certain  calcium  ionophores  have  recently been 
shown to enhance action of TPA  in promoting epidermal 
differentiation (Jaken and Yuspa,  1988). 
While calcium is necessary for certain features of terminal 
differentiation (e.g.,  desmosome  formation,  stratification 
and transglutaminase activation) in human keratinocytes, its 
effects often seem more pronounced in regulating differentia- 
tion-specific changes in cellular architecture, than altera- 
tions in gene expression. Thus for example, when human 
cells are cultured in low calcium medium, withdrawal from 
the  cell  cycle and involucrin synthesis still occur  (Watt, 
1984). Similarly, while desmosomes cannot assemble in low 
calcium, desmosomal proteins are nevertheless synthesized 
in both low and high calcium medium (Watt et al.,  1984; 
Duden and Franke, 1988). Finally, for human keratinocytes, 
high calcium medium does not induce appreciable levels of 
K1/K10 and filaggrin expression (Fuchs and Green,  1981; 
Fleckman et al., 1985). Mouse keratinocytes seem to differ 
from human cells in their sensitivity to calcium. Recently, 
it  was  discovered  that  substantial  K1/K10  expression  in 
mouse epidermal cells can be induced by a narrow window 
of calcium concentrations (Roop et al.,  1987; Yuspa et al., 
1989).  In addition, Glick et al. (1990) showed that calcium 
induces a marked increase in TGF/T2 mRNA expression in 
mouse keratinocytes, thereby implicating calcium in both 
early and late stages of terminal differentiation. Hence, like 
other known regulators of epidermal differentiation, calcium 
seems to have pleiotropic effects, and furthermore, it differs 
from other known regulators in having a distinct positive 
influence on many aspects of terminal differentiation. While 
additional experiments will be necessary to elucidate the 
precise relation between calcium, TGF-/3s and retinoids, it 
seems clear that calcium is intimately involved in the com- 
plex regulatory mechanisms underlying the balance between 
growth and keratinization. 
Terminal Differentiation: Active or Passive? 
Among the most fundamental of unresolved questions is 
when does an epidermal cell undergo a commitment to ter- 
minally differentiate? Is the commitment reached before a 
cell leaves the basal layer, or does it occur after a cell has 
left this layer? If commitment takes place in the basal layer, 
then the population of basal keratinocytes should be hetero- 
geneous. Certainly, as judged by their cell cycling proper- 
ties, this appears to be the case (Barrandon and Green, 1987; 
Potten and Morris,  1988).  By this criterion, there seem to 
be at least two populations of basal cells. One population, 
stem cells, have a long lifespan, a  long cycling phase and 
short S period (for review, see Potten and Morris, 1988). The 
second population, transit amplifying cells or paraclones, 
undergo only a limited number of  divisions before terminally 
differentiating (Barrandon  and  Green,  1987).  Moreover, 
paraclones seem to arise from stem cells, suggesting further 
that a sequence of events leading to terminal differentiation 
may take place before movement of a cell out of the basal 
layer (Barrandon and Green,  1987). 
A  priori,  it might seem attractive to visualize terminal 
differentiation as a passive event, where an occupied basal 
layer provides the force to push a cell to the first suprabasal 
layer, and thereafter, its absence of  contact with the basement 
membrane might trigger the cascade of events (including cell 
cycle withdrawal) leading to keratinization. While this no- 
tion seems plausible, this simple model does not account for 
why there are two to three layers of cells with biochemical 
and morphological characteristics of  basal cells in squamous 
cell carcinoma cells cultured on floating lattices of collagen 
and fibroblasts (Stoler et al., 1988; Kopan and Fuchs, 1989). 
Moreover, it does not explain why certain features of epider- 
mal differentiation can be induced in basal cells before their 
exit from the innermost layer (Watt, 1984; Roop et al., 1987; 
Choi and Fuchs, 1990). Thus, it seems more likely that ces- 
sation of cell division can be uncoupled from loss of base- 
ment membrane contact and is key to when a cell shifts to 
a program of gene expression leading to terminal differentia- 
tion. However, as indicated previously, cell cycle withdrawal 
does not seem to be sufficient for an irreversible commitment 
to terminal differentiation, and it could be that additional 
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Further studies will be  necessary to distinguish between 
these possibilities. 
In summary, we are left with a picture whereby a keratino- 
cyte becomes a  terminally differentiating cell as a  conse- 
quence of  a series of  biochemical checks and balances. There 
seems to be several early changes necessary for entry into 
the differentiation pathway, and among these are likely to be 
TGF-Bs and other agents that slow or inhibit DNA synthesis 
and cell division. In normal epidermis, movement of a cell 
from its basement membrane may contribute to, but does not 
seem  sufficient for,  instigating a  cascade  of biochemical 
changes that culminate in irreversibly sealing the differentia- 
tive fate ofa keratinocyte. Once a basal cell has left the inner- 
most layer and its biochemical program has begun to change, 
it seems to be further influenced by retinoids, TGF-fls and 
calcium primarily in a fashion that appears to allow retailor- 
ing of the architecture of the keratinizing layers above.  Fur- 
ther investigation will be necessary to determine whether 
this capacity to redesign the suprabasal program of differen- 
tiation affects basal as well as suprabasal cells. 
Molecular Controls of  Epidermal Gene  Expression: 
Master Regulators of  Kerotinocyte Fate? 
There is compelling evidence from other differentiation sys- 
tems  that  expression  of a  few  transcriptional  regulatory 
genes are central to the manifestation and maintenance of  the 
differentiative state (Blau et al.,  1983;  Lassar et ai.,  1986; 
Herr  et al.,  1988;  Mangaiam et  al.,  1989;  Kemler and 
Schaffner, 1990).  Perhaps the best understood master regu- 
lators of differentiation are the family of Myo D proteins, 
transcription factors that control expression of a large num- 
ber of skeletal muscle genes (Davis et al., 1990). These pro- 
teins are expressed during early embryonic development at 
the  time of myoblast differentiation, and their  levels  are 
elevated in skeletal muscle (Sassoon et al.,  1989).  Expres- 
sion of Myo D in certain fibroblast cell lines in vitro appears 
to be sufficient to convert them into myoblasts (Lassar et al., 
1986). While the Myo D family plays a central role in myo- 
blast differentiation, regulation of these regulators involves 
a complex program of transcriptional and posttranslational 
controls, and moreover, there may be more to muscle differ- 
entiation than Myo D and its family (see for example Schafer 
et al., 1990). Hence for muscle, at least one family of central 
regulators controlling the balance of growth and differentia- 
tion are transcription factors, which are controlled by a dy- 
namic group of intracellular and extracellular regulators. 
Based  on  muscle  and  other  differentiation systems,  it 
seems that a knowledge of the major transcription factors 
controlling keratinocyte-specific gene expression will be of 
central importance in the quest for elucidating the molecular 
mechanisms underlying epidermal differentiation. While lit- 
tle is presently known about keratinocyte transcription fac- 
tors, there are a number of keratinocyte genes that have al- 
ready been isolated and characterized, and which serve as 
a foundation for pursuing these factors. These include genes 
encoding: (a) the basal keratins K5 (Lersch et al., 1989) and 
K14 (Marchuk et al., 1984);  (b) the suprabasal keratins K1 
(Johnson et al., 1985), K10 (Krieg et al., 1985; Rieger et al., 
1985;  Rieger and Franke,  1988),  K6 (Tyner et al.,  1985), 
and K16 (Rosenberg et al., 1988); (c) the cornified envelope 
protein, involucrin (Eckert and Green, 1986); and (d) filag- 
grin (Rothnagel and Steinert, 1990). Sequence comparisons 
have provided a few clues as to possible common regulatory 
elements involved in controlling keratinocyte-specific gene 
expression. One of these is the CK 8-mer sequence 5' A A 
N C C A A A 3' found upstream from a number of  epidermal 
genes (Blessing et al., 1987; Cripe et al., 1987). Blessing et 
al.  (1989)  showed that a  ,,o90-bp  fragment containing a 
TATA box and a CK 8-mer sequence provided a 4x enhance- 
ment of expression of a CAT reporter gene, but Chin et al. 
(1989) were unable to demonstrate function for the CK 8-mer 
sequence in the E6/E7 promoter of a human papillomavirus 
genome. Hence, if a CK 8-mer-like sequence is involved in 
keratinocyte gene expression, it may act in concert either in 
multiple copies or with other regulatory elements in addition 
to a TATA box. 
Recently, we identified a different sequence, 5' G C C T 
G C A G G C 3' located 5' from the TATA box of the human 
K14 gene, that appears to act in conjunction with a distal ele- 
ment to control its transcription in keratinocytes (Leask et 
al.,  1990).  The sequence is also the target for the binding 
of an AP2-1ike factor, KER1, which is especially abundant 
in keratinocytes, and present in lower amounts in simple epi- 
thelial cells. While we do not yet know the extent to which 
KER1 regulates the expression of other keratinocyte-specific 
genes, it is intriguing to note that at least one gene, encoding 
the human differentiation-specific keratin K1, contains a se- 
quence which competes for the binding of KER1 to the K14 
gene (Leask et al., 1990). In addition, if KER1 is AP2, then 
AP2  may be  generally used  in  controlling keratinocyte- 
specific expression, since classical AP2 sites exist in other 
keratinocyte genes, including the gene encoding KS, i.e., the 
partner to K14. 
That  KER1  might  be  important  in  controlling  kera- 
tinocyte-specific  gene  expression  is  underscored  by  re- 
cent studies on the promoter of a keratin gene, XK81A1, ex- 
pressed in the outer ectoderm after midblastula transition 
during Xenopus development (Snape et al., 1990).  By using 
methylation interference and footprint analyses, Snape et al. 
(1990) have identified an imperfect palindrome 5' A C C C 
T G A G G C T 3' that binds a nuclear factor, KTF-1, en- 
riched in embryonic ectodermal fractions. While prelimi- 
nary studies have not revealed competition of the Xenopus 
sequence  for binding of KER1  to  the  human K14  gene, 
nevertheless,  the  similarities betwee~ the  sequences  and 
KER1/KTF-1 binding properties suggest that mechanisms for 
epidermal gene expression in vertebrates might be distantly 
related (Leask et ai., 1990).  Interestingly, temporal expres- 
sion of the Xenopus  XKSIA1 (Snape et ai., 1990) and the hu- 
man K14 gene (Kopan and Fuchs, 1989) coincide with com- 
mitment of a cell to keratinocyte development, suggesting 
the interesting possibility that one of the factors controlling 
the expression of these genes could be a candidate for a mas- 
ter regulator of keratinocyte gene expression. 
While there is simply not enough known about the mo- 
lecular mechanisms that act to regulate the expression of 
keratinocyte-specific genes, it seems likely that this knowl- 
edge will be essential to elucidating the missing steps in- 
volved in controlling keratinocyte fate and commitment to 
terminal differentiation. In the coming years, a major focus 
in the field of epidermal  differentiation will be  on kera- 
tinocyte-specific transcription factors as possible mediators 
of extracellular regulators and keratinocyte fate. 
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